Efficacy of Laflavon in Lowering Triglycerides and Raising High-Density Lipoprotein (HDL)
Clinical trial NCT01286909 · UNKNOWN
Trial details
- NCT number
- NCT01286909
- Sponsor
- Omicron Pharmaceuticals
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2011-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.